217 related articles for article (PubMed ID: 31528332)
1. A clinico-genomic analysis of soft tissue sarcoma patients reveals CDKN2A deletion as a biomarker for poor prognosis.
Bui NQ; Przybyl J; Trabucco SE; Frampton G; Hastie T; van de Rijn M; Ganjoo KN
Clin Sarcoma Res; 2019; 9():12. PubMed ID: 31528332
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive genomic analysis of primary bone sarcomas reveals different genetic patterns compared with soft tissue sarcomas.
Zhang Q; Yang Y; You X; Ju Y; Zhang Q; Sun T; Liu W
Front Oncol; 2023; 13():1173275. PubMed ID: 37546405
[TBL] [Abstract][Full Text] [Related]
3. Targetable Alterations in Adult Patients With Soft-Tissue Sarcomas: Insights for Personalized Therapy.
Lucchesi C; Khalifa E; Laizet Y; Soubeyran I; Mathoulin-Pelissier S; Chomienne C; Italiano A
JAMA Oncol; 2018 Oct; 4(10):1398-1404. PubMed ID: 29801054
[TBL] [Abstract][Full Text] [Related]
4. Distinct genomic landscapes in radiation-associated angiosarcoma compared with other radiation-associated sarcoma histologies.
Dermawan JK; Chi P; Tap WD; Rosenbaum E; D'Angelo S; Alektiar KM; Antonescu CR
J Pathol; 2023 Aug; 260(4):465-477. PubMed ID: 37350195
[TBL] [Abstract][Full Text] [Related]
5. Genomic profiling of pleomorphic rhabdomyosarcoma reveals a genomic signature distinct from that of embryonal rhabdomyosarcoma.
Saoud C; Dermawan JK; Sharma AE; Tap W; Wexler LH; Antonescu CR
Genes Chromosomes Cancer; 2024 May; 63(5):e23238. PubMed ID: 38722224
[TBL] [Abstract][Full Text] [Related]
6. Determining the prognostic significance of alternative splicing events in soft tissue sarcoma using data from The Cancer Genome Atlas.
Yang X; Huang WT; He RQ; Ma J; Lin P; Xie ZC; Ma FC; Chen G
J Transl Med; 2019 Aug; 17(1):283. PubMed ID: 31443718
[TBL] [Abstract][Full Text] [Related]
7. Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients.
Gan M; Zhang C; Qiu L; Wang Y; Bao H; Yu R; Liu R; Wu X; Shao Y; Hou P; Fei Z
Cancer Med; 2022 Nov; 11(21):4070-4078. PubMed ID: 35586877
[TBL] [Abstract][Full Text] [Related]
8. Genomic alterations predictive of poor clinical outcomes in pan-cancer.
Seldon CS; Meiyappan K; Hoffman H; Guo JA; Goel N; Hwang WL; Nguyen PL; Mahal BA; Alshalalfa M
Oncotarget; 2022; 13():1069-1077. PubMed ID: 36187555
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential.
Francis P; Namløs HM; Müller C; Edén P; Fernebro J; Berner JM; Bjerkehagen B; Akerman M; Bendahl PO; Isinger A; Rydholm A; Myklebost O; Nilbert M
BMC Genomics; 2007 Mar; 8():73. PubMed ID: 17359542
[TBL] [Abstract][Full Text] [Related]
10. Deconvolution of sarcoma methylomes reveals varying degrees of immune cell infiltrates with association to genomic aberrations.
Simon M; Mughal SS; Horak P; Uhrig S; Buchloh J; Aybey B; Stenzinger A; Glimm H; Fröhling S; Brors B; Imbusch CD
J Transl Med; 2021 May; 19(1):204. PubMed ID: 33980253
[TBL] [Abstract][Full Text] [Related]
11. Integration of genomic copy number variations and chemotherapy-response biomarkers in pediatric sarcoma.
Cheng L; Pandya PH; Liu E; Chandra P; Wang L; Murray ME; Carter J; Ferguson M; Saadatzadeh MR; Bijangi-Visheshsaraei K; Marshall M; Li L; Pollok KE; Renbarger JL
BMC Med Genomics; 2019 Jan; 12(Suppl 1):23. PubMed ID: 30704460
[TBL] [Abstract][Full Text] [Related]
12. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
[TBL] [Abstract][Full Text] [Related]
13. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in
Das S; Idate R; Lana SE; Regan DP; Duval DL
bioRxiv; 2023 Jan; ():. PubMed ID: 36711648
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Genomic Profiling of Adult Renal Sarcomas Provides Insight into Disease Biology and Opportunities for Targeted Therapies.
Yakirevich E; Madison R; Fridman E; Mangray S; Carneiro BA; Lu S; Cooke M; Bratslavsky G; Webster J; Ross JS; Ali SM
Eur Urol Oncol; 2021 Apr; 4(2):282-288. PubMed ID: 31412008
[TBL] [Abstract][Full Text] [Related]
15. Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets.
Heitzer E; Sunitsch S; Gilg MM; Lohberger B; Rinner B; Kashofer K; Stündl N; Ulz P; Szkandera J; Leithner A; Liegl-Atzwanger B
Mod Pathol; 2017 Dec; 30(12):1698-1709. PubMed ID: 28776571
[TBL] [Abstract][Full Text] [Related]
16. Genomic Profiling in Patients With Malignant Peripheral Nerve Sheath Tumors Reveals Multiple Pathways With Targetable Mutations.
Kaplan HG; Rostad S; Ross JS; Ali SM; Millis SZ
J Natl Compr Canc Netw; 2018 Aug; 16(8):967-974. PubMed ID: 30099373
[No Abstract] [Full Text] [Related]
17. Integrated analysis of canine soft tissue sarcomas identifies recurrent mutations in TP53, KMT genes and PDGFB fusions.
Das S; Idate R; Lana SE; Regan DP; Duval DL
Sci Rep; 2023 Jun; 13(1):10422. PubMed ID: 37369741
[TBL] [Abstract][Full Text] [Related]
18. Molecular signatures of BRCAness analysis identifies PARP inhibitor Niraparib as a novel targeted therapeutic strategy for soft tissue Sarcomas.
Li H; Tu J; Zhao Z; Chen L; Qu Y; Li H; Yao H; Wang X; Lee DF; Shen J; Wen L; Huang G; Xie X
Theranostics; 2020; 10(21):9477-9494. PubMed ID: 32863940
[No Abstract] [Full Text] [Related]
19. Potential application of genomic profiling for the diagnosis and treatment of patients with sarcoma.
Xu L; Xie X; Shi X; Zhang P; Liu A; Wang J; Zhang B
Oncol Lett; 2021 May; 21(5):353. PubMed ID: 33747210
[TBL] [Abstract][Full Text] [Related]
20. Molecular profiling of soft-tissue sarcomas with FoundationOne
Scheipl S; Brcic I; Moser T; Fischerauer S; Riedl J; Bergovec M; Smolle M; Posch F; Gerger A; Pichler M; Stoeger H; Leithner A; Heitzer E; Liegl-Atzwanger B; Szkandera J
Ther Adv Med Oncol; 2021; 13():17588359211029125. PubMed ID: 34367342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
